Cancer vaccines are back, revitalized.
Med
; 4(7): 395-397, 2023 Jul 14.
Article
em En
| MEDLINE
| ID: mdl-37453413
ABSTRACT
Cancer vaccines are beginning to deliver positive clinical results, particularly in the adjuvant setting with lipo-nanoparticle mRNA formulations used to elicit neoantigen responses. In a recent report in Nature, Rojas et al. show this may even be possible in patients with pancreatic cancer.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pancreáticas
/
Vacinas Anticâncer
/
Nanopartículas
Limite:
Humans
Idioma:
En
Revista:
Med
Ano de publicação:
2023
Tipo de documento:
Article